Loading Valuation Snapshot...
Stock DNA
Pharmaceuticals & Biotechnology
INR 3 Cr ()
16.00
21
0.00%
0.00
0.00%
0.30
Revenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Dec 2025)
Net Profit:
0 Cr
Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-38.78%
0%
-38.78%
6 Months
-45.45%
0%
-45.45%
1 Year
-20.0%
0%
-20.0%
2 Years
-46.24%
0%
-46.24%
3 Years
-23.47%
0%
-23.47%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Shyama Computro. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available
News
No Recent News for the Company
Announcements 
Closure of Trading Window
20-Mar-2026 | Source : BSEPlease find Enclosed
Announcement under Regulation 30 (LODR)-Newspaper Publication
10-Feb-2026 | Source : BSEWe are enclosing copies of Newspaper Publication.
Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On 29Th January 2026 In Terms Of Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
09-Feb-2026 | Source : BSEWe are enclosing outcome of Board Meeting.
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-5.09%
EBIT Growth (5y)
1.36%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-1.96%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
21
Price to Book Value
0.30
EV to EBIT
3.00
EV to EBITDA
3.00
EV to Capital Employed
0.30
EV to Sales
3.00
PEG Ratio
0.34
Dividend Yield
NA
ROCE (Latest)
0.59%
ROE (Latest)
1.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
Bearish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
None
Highest Public shareholder
Sunil Mehta (4.57%)
Individual Investors Holdings
76.25%
Quarterly Results Snapshot (Standalone) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
0.07
0.06
16.67%
Operating Profit (PBDIT) excl Other Income
0.03
0.02
50.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.04
0.02
100.00%
Operating Profit Margin (Excl OI)
42.86%
33.33%
9.53%
Values in Rs Cr.
Net Sales
YoY Growth in quarter ended Dec 2025 is 16.67% vs 20.00% in Dec 2024
Standalone Net Profit
YoY Growth in quarter ended Dec 2025 is 100.00% vs 0.00% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
0.25
0.21
19.05%
Operating Profit (PBDIT) excl Other Income
-0.01
-0.05
80.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.15
0.11
36.36%
Operating Profit Margin (Excl OI)
-4.00%
-23.81%
19.81%
Values in Rs Cr.
Net Sales
YoY Growth in year ended Mar 2025 is 19.05% vs 40.00% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 36.36% vs 10.00% in Mar 2024